Pfizer

WHO ‘strongly recommends’ Pfizer's Covid-19 pill for at-risk patients: Report

The WHO experts said that US pharma giant Pfizer’s combination of nirmatrelvir and ritonavir was the “superior choice” of treatment for unvaccinated, elderly or immunocompromised people with Covid-19, according to AFP.

Apr 22, 2022, 08:16 AM IST

Moderna seeks FDA approval for fourth Covid vaccine to be used as booster shot

Moderna is now seeking Food and Drug Administration (FDA) approval for its fourth shot of the Covid-19 vaccine to be administered as a booster dose in eligible adults.

Mar 18, 2022, 09:55 AM IST

Pfizer, BioNTech asks FDA to allow COVID-19 vaccine for kids under 5 years of age

For kids under 5, Pfizer's study is giving participants two shots three weeks apart, followed by a third dose at least two months later. The company is testing whether the youngsters produce antibody levels similar to those known to protect teens and young adults.

Feb 02, 2022, 06:57 AM IST

Vaccine for Omicron! Pfizer's new jab likely to be ready by March

Pfizer and partner BioNTech SE are working on both an Omicron-targeted vaccine variant as well as a shot that would include both the previous vaccine as well as vaccine targeted at the Omicron variant.

Jan 11, 2022, 08:01 AM IST

Even triple vaccination cannot limit Omicron spread: BioNTech CEO

Pfizer/BioNTech is developing a vaccine against Omicron variant that should be out by March 2022.

Dec 21, 2021, 09:08 AM IST

COVID-19 could become endemic by 2024, predicts Pfizer amid Omicron scare

Prior to the Omicron variant, top U.S. disease doctor Anthony Fauci forecast the pandemic would end in 2022 in the United States.

Dec 18, 2021, 11:28 AM IST

Data indicate Omicron is milder and better at evading vaccines

The analysis was based on examining more than 211,000 COVID-19 test results that date from Sept 1 to Dec 7.

Dec 14, 2021, 23:07 PM IST

Pfizer, BioNTech not sure on vaccine effectiveness on new Covid variant Omicron

The pharmaceutical companies underscored that they started working on making their vaccine adaptable to new possible variants months ago.

Nov 27, 2021, 08:02 AM IST

Pfizer agrees to let other companies make its Covid-19 pill to be used in 95 countries

The deal excludes some large countries that have suffered devastating coronavirus outbreaks.

Nov 16, 2021, 23:10 PM IST

Antiviral pill cuts risk of severe COVID-19 by 89%: Pfizer

The results appear to surpass those seen with Merck & Co Inc's pill, molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious illness. Full trial data is not yet available from either company.

Nov 05, 2021, 18:22 PM IST

Good news! US formally recommends Pfizer COVID-19 vaccine for children aged 5-11

"Today, following a rigorous review and authorization process by the FDA, the CDC has formally recommended the Pfizer COVID-19 vaccine for children 5-11. This is encouraging news, and a major step forward for our nation in our fight to defeat the virus," tweeted US President Joe Biden.

Nov 03, 2021, 08:18 AM IST

US backs Pfizer's low-dose COVID-19 vaccine for kids, FDA approval expected soon

A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine's benefits in preventing COVID-19 in that age group outweigh any potential risks including a heart-related side effect that's been very rare in teens and young adults despite their use of a much higher shot dose.

Oct 27, 2021, 10:17 AM IST

COVID-19 vaccine nearly 91% effective in kids aged 5 to 11, says Pfizer

 Pfizer's COVID-19 vaccine is more than 90% effective in children, and if regulators give a nod shots could begin in early November. 

Oct 23, 2021, 09:33 AM IST

US President Joe Biden took the third dose of the vaccine

Giving information, the White House said that US President Joe Biden has received his COVID-19 vaccine booster shot at the White House. Biden has received the third dose of the Pfizer vaccine after federal health officials approved a booster dose.

Sep 28, 2021, 17:06 PM IST

COVID pandemic to get over in a year? After Moderna chief, now Pfizer says the same thing

Even former Food and Drug Administration chief Scott Gottlieb has said that the current wave of COVID-19 cases driven by the Delta coronavirus variant is going to be the end of COVID, but it may linger around as an endemic.

Sep 28, 2021, 13:15 PM IST

FDA approves booster shots of Pfizer COVID-19 vaccine for elderly, high-risk Americans

The booster dose is to be administered at least six months after completion of the second dose, and the authorization would include people most susceptible to severe disease and those in jobs that left them at risk, the FDA said.

Sep 23, 2021, 06:26 AM IST

Pfizer initially rejected BioNTech's offer to develop COVID vaccine

BioNTech founders revealed the story of initial rejection by Pfizer in a new book titled The Vaccine, written by journalist Joe Miller, to be released this week. 

Sep 14, 2021, 16:06 PM IST

COVID-19: Pfizer booster shot to start by September 20 in US, hints Anthony Fauci

"We hope that Moderna would also be able to do it, so we could do it simultaneously," the country's top infectious disease expert Anthony Fauci said.

Sep 06, 2021, 18:55 PM IST

Contracting Covid 19 earlier doesn't mean you have a better immunity against coronavirus now

A new study suggests that the two doses of vaccination is necessary for people who have contracted the coronavirus earlier.

Sep 01, 2021, 07:41 AM IST

'Pfizer COVID vaccine may be authorised for children aged between 5 to 12 by October'

Currently of the three COVID-19 vaccines used in the US, only the Pfizer-BioNTech vaccine has been granted the emergency use authorisation for children aged 12 and older.

Aug 30, 2021, 13:45 PM IST